Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Arena forms diabetes collaboration with Ortho-McNeil

Dec. 23, 2004

Approval for rhC1INH IND application

Dec. 23, 2004

WinRho SDF completes European mutual recognition procedure

Dec. 23, 2004

Cognitive improvements found with epoetin alfa in anemic patients with hematologic malignancies

Dec. 22, 2004

New patent application covers antidiabetic agents

Dec. 22, 2004

TAK-559 placed on hold

Dec. 21, 2004

Myozyme MAA accepted in Europe for Pompe disease

Dec. 21, 2004

Sankyo patent claims chromane analogues and their use in diabetes, hyperlipidemia, etc.

Dec. 21, 2004

A new series of beta3 receptor agonists in early development at Dainippon

Dec. 21, 2004

Abbott discloses MCH receptor antagonists in a recent patent

Dec. 21, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Genescience presents STAT6 degrader for atopic dermatitis
BioWorld Science
Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation....
Roche reports new TREM2 agonists
BioWorld Science
F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...